weight loss
It looks like you’re getting ahead of the curve! As of mid-2026, Orforglipron (which Eli Lilly has branded as Foundayo) is the “next big thing” in metabolic health. Because it is a non-peptide, oral GLP-1 receptor agonist, it’s basically the pill-form successor to injectable treatments like Mounjaro.
14
May
May
Foundayo (Orforglipron): The Future of Weight Management Welcome to the next generation of metabolic health. At WellnessTabs, we are proud to facilitate access to Foundayo, Eli Lilly’s breakthrough oral GLP-1 medication. Designed for those who seek the power of clinical weight loss without the need for weekly injections, Foundayo is redefining convenience and efficacy. What is Foundayo? […]